تخطى إلى المحتوى / Skip to content
Clinical Reference Hub

Delirium

Acute disturbance in attention, awareness, and cognition that develops over a short period.

Medical disclaimer: This page is an educational clinical-decision-support reference for licensed healthcare professionals. It is not a substitute for professional medical advice, diagnosis, or treatment. If you are a patient with symptoms, consult a qualified physician. Always verify dosing and guidance against current clinical guidelines and the cited references.

🩺What is Delirium?

The Richmond Agitation-Sedation Scale (RASS) was developed by a multidisciplinary team of critical care physicians, nurses, and pharmacists at Virginia Commonwealth University, with the original validation study published by Sessler et al. in the American Journal of Respiratory and Critical Care Medicine in 2002. The scale emerged from a need for a standardized, reliable tool to assess level of sedation and agitation in critically ill patients, addressing limitations of earlier scales like the Ramsay Sedation Scale. RASS is a 10-level ordinal scale ranging from +4 (combative, posing immediate danger to staff) through 0 (alert and calm) to -5 (unarousable, no response to voice or physical stimulation). The scale has demonstrated excellent inter-rater reliability (weighted kappa > 0.90) across diverse ICU populations and nursing shifts, and it has been validated against other sedation measures and neurophysiologic monitoring. The Society of Critical Care Medicine's Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS) in Adult ICU Patients, published in 2018, explicitly recommend RASS as the preferred sedation assessment tool in mechanically ventilated patients. RASS is also a prerequisite for delirium assessment using the Confusion Assessment Method for the ICU (CAM-ICU), as CAM-ICU cannot be performed in patients with RASS -4 or -5. The scale is now the most widely used sedation assessment instrument in ICUs globally, integrated into sedation protocols, daily interruption bundles, and quality improvement initiatives aimed at reducing oversedation, ventilator days, and ICU length of stay.

ICD-10 Classification Code:F05

🏥Signs & Symptoms

The following clinical signs and symptoms are commonly assessed when evaluating Delirium:

  • Acute onset and fluctuating course of confusion
  • Inattention and difficulty focusing
  • Disorientation to time, place, or person
  • Altered level of consciousness (hypervigilance, lethargy, or stupor)
  • Perceptual disturbances, including hallucinations
  • Disorganized thinking and agitation
  • Reversed sleep-wake cycle

🔬Causes & Etiology

Delirium is an acute, usually reversible neuropsychiatric syndrome caused by an underlying medical, surgical, or pharmacologic trigger in a vulnerable brain.

Common triggers include infections, metabolic derangements, medications, hypoxia, electrolyte imbalance, surgery, and pain.

⚠️Risk Factors

The following factors are known to increase the risk of developing or worsening Delirium:

  • Older age and pre-existing cognitive impairment
  • Hospitalization, especially in intensive care
  • Surgery, especially hip fracture and cardiac surgery
  • Polypharmacy and psychoactive medications
  • Sensory impairment, dehydration, and malnutrition
  • Severe acute illness and organ failure

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Delirium:

  • RASS Score Calculator

    The Richmond Agitation-Sedation Scale (RASS) is a validated 10-level scale used in ICU to assess the level of sedation and agitation in patients. It ranges from +4 (combative) to -5 (unarousable).

  • CAM-ICU — Confusion Assessment Method for ICU Delirium

    The Confusion Assessment Method for the ICU (CAM-ICU) is a validated, rapid bedside assessment tool for detecting delirium in critically ill patients, using a 4-feature algorithm to determine the presence or absence of delirium.

  • MMSE — Mini-Mental State Examination

    The Mini-Mental State Examination (MMSE) is a 30-point cognitive screening tool widely used in clinical and research settings to assess cognitive impairment and track dementia progression over time.

  • Mini-Cog Dementia Screening

    The Mini-Cog is a brief 3-minute cognitive screening tool that combines 3-word recall with a clock-drawing test. It is validated for dementia screening in primary care and geriatric settings, with minimal education and language bias.

🧬Diagnostic Logic & Scoring Breakdown

RASS is a single ordinal scale that follows a structured, stepwise assessment protocol. The assessment begins by observing the patient at rest without stimulation. If the patient is fully alert and shows any degree of agitation or restlessness, the clinician scores from 0 (alert and calm) upward to +4 (combative) based on observed behavior. A score of +1 is given for restless or anxious but non-aggressive movements; +2 for frequent non-purposeful movement or pulling at tubes; +3 for very agitated behavior such as attempting to remove catheters or striking staff; and +4 for overtly combative or violent behavior posing immediate danger. If the patient is not fully alert, the clinician proceeds to step two: verbal stimulation. The patient is called by name in a normal voice, and if necessary, with a louder command to open eyes. Response to verbal stimulation yields scores of -1 (drowsy but awakens to voice with sustained consciousness for more than 10 seconds), -2 (awakens briefly to voice with eye opening for less than 10 seconds), or -3 (any movement or eye opening to voice but without sustained eye contact). If there is no response to verbal stimulation, step three involves physical stimulation: gentle shaking of the shoulder followed by rubbing the sternum if needed. Response only to physical stimulation yields -4 (movement to physical stimulation but no response to voice), while no response to any stimulation yields -5 (unarousable). The structured protocol ensures consistency across different assessors. The target RASS range depends on the clinical context: for most mechanically ventilated patients, the PADIS guidelines recommend targeting RASS 0 to -1 (light sedation). For patients with severe ARDS or elevated intracranial pressure, deeper sedation (RASS -2 to -4) may be appropriate. Light sedation targets (RASS 0 to +1) are appropriate for post-operative patients undergoing rapid weaning.

📢Clinical Significance & Implications

RASS is the most widely used sedation assessment instrument in ICUs worldwide and is formally recommended by the Society of Critical Care Medicine's PADIS (Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption) guidelines published in Critical Care Medicine in 2018. The guidelines recommend routine monitoring of sedation with a validated tool such as RASS at least every 4 hours and whenever sedation is adjusted. The target RASS score should be individualized based on patient-specific factors: for most mechanically ventilated patients, a target of RASS 0 to -1 (light sedation) is recommended as it is associated with reduced duration of mechanical ventilation, shorter ICU length of stay, decreased incidence of delirium, and lower rates of tracheostomy. Light sedation targets (RASS 0 to +1) are appropriate for patients undergoing daily sedation interruption or rapid weaning protocols. Deeper sedation targets (RASS -2 to -4) may be indicated for patients with severe ARDS requiring lung-protective ventilation with neuromuscular blockade, those with elevated intracranial pressure, status epilepticus, or refractory hypoxemia. The implementation of nurse-driven sedation protocols with explicit RASS targets has been shown to reduce total sedative exposure, decrease variability in sedation practice, and improve clinical outcomes. Daily sedation interruption (DSI), also known as a "sedation vacation," involves holding sedative infusions until the patient reaches RASS 0 to -1 or demonstrates awakening. DSI guided by RASS has been demonstrated in randomized trials to reduce duration of mechanical ventilation and ICU stay. RASS also serves as the first step in delirium screening — CAM-ICU can only be performed when RASS is -3 or higher. An RASS of -4 or -5 precludes delirium assessment and should prompt evaluation of sedation depth.

🛡️Prevention & Management

Evidence-based prevention and management strategies for Delirium include:

  • Non-pharmacologic bundles: reorientation, early mobilization, and family involvement
  • Avoidance of unnecessary psychoactive and anticholinergic medications
  • Adequate hydration, nutrition, and pain control
  • Sensory aids (glasses, hearing aids) and sleep hygiene
  • Early treatment of the underlying medical cause

Complications & Prognosis

Without proper management, Delirium may lead to the following complications:

Prolonged hospital stay, functional decline, and increased falls and injury.

Higher mortality and risk of institutionalization in hospitalized patients.

Long-term cognitive decline, especially in patients with pre-existing dementia.

💡 Clinical Assessment Scenario Example

A 55-year-old male with a history of hypertension and diabetes was admitted to the ICU three days ago for severe community-acquired pneumonia requiring mechanical ventilation. He is on a propofol infusion for sedation, currently at 30 mcg/kg/min. The nurse performs a routine RASS assessment as part of the 8 AM sedation protocol. Step 1 — Observation at rest: the patient is lying quietly with eyes closed and does not respond to the environment spontaneously. He is not alert, so the nurse proceeds to step 2 — Verbal stimulation. The nurse calls the patient by name in a normal voice: "Mr. Ahmed, open your eyes." The patient opens his eyes briefly, makes eye contact for approximately 5 seconds, but then closes his eyes again. He does not sustain attention or follow commands. According to the RASS protocol, this response corresponds to RASS -2 (light sedation): the patient awakens briefly to voice with eye opening for less than 10 seconds. The target RASS for this patient per the ICU sedation protocol is 0 to -1 (light sedation), which allows neurological assessment, participation in daily sedation interruption, and readiness-for-extubation evaluation. The current RASS of -2 indicates the patient is slightly oversedated. The nurse adjusts the propofol infusion rate down to 25 mcg/kg/min per the sedation protocol and will reassess RASS in 30 minutes. The patient's pain is also assessed using the Critical-Care Pain Observation Tool (CPOT), which scores 0, indicating adequate pain control. A CAM-ICU assessment is performed — since RASS is -2 (above -3), delirium assessment is possible, and the patient tests negative for delirium. The plan includes continued RASS monitoring every 4 hours, daily sedation interruption tomorrow morning, and assessment for spontaneous breathing trial readiness.

💊Common Medications & Interventions

The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Delirium:

PropofolSedative-hypnotic (GABA agonist)
DexmedetomidineAlpha-2 agonist (sedative/analgesic)
MidazolamBenzodiazepine (GABA agonist)
HaloperidolAntipsychotic (Typical)
QuetiapineAntipsychotic (Atypical)
DonepezilCholinesterase Inhibitor
RivastigmineCholinesterase Inhibitor
MemantineNMDA Receptor Antagonist

⚠️Clinical Assessment Pitfalls

  • Mistake: Scoring RASS without attempting stimulation

    Correction: If the patient is not alert, begin with verbal stimulation (call name, command). If no response, proceed to physical stimulation (shake shoulder, rub sternum).

  • Mistake: Confusing RASS with GCS

    Correction: RASS measures sedation/agitation level; GCS measures consciousness. They serve different purposes — RASS for sedation titration, GCS for neurological assessment.

  • Mistake: Not considering pain before sedation

    Correction: In agitated patients, assess and treat pain first (with CPOT or BPS scale) before increasing sedation. Analgesia-first approach reduces sedation needs.

  • Mistake: Attempting CAM-ICU when RASS is -4 or -5

    Correction: CAM-ICU delirium assessment requires RASS -3 or higher. If RASS is -4 or -5, reassess after reducing sedation depth before attempting delirium evaluation.

  • Mistake: Not reassessing RASS after changes in sedation or clinical status

    Correction: RASS should be reassessed within 15-30 minutes after any sedation adjustment and whenever clinical status changes. Prompt assessment prevents oversedation or under-sedation.

  • Mistake: Assessing CAM-ICU in deeply sedated or unarousable patients

    Correction: If the patient has a RASS score of -4 (responsive only to physical stimulation) or -5 (unresponsive), the CAM-ICU assessment cannot be performed. Document the patient as "unable to assess" due to deep sedation and reassess when lighter sedation is achieved.

  • Mistake: Confusing delirium with dementia in CAM-ICU assessment

    Correction: Delirium has acute onset and fluctuating course (Feature 1) while dementia is chronic and progressive. CAM-ICU assesses for delirium superimposed on dementia. Assess Feature 1 carefully — ask family or review nursing notes for acute change from baseline. A patient with dementia can still have delirium.

  • Mistake: Using CAM-ICU only once at admission

    Correction: Delirium fluctuates and can develop at any point during ICU stay. CAM-ICU should be performed every shift (12-hourly) and whenever there is a change in mental status. Early detection of new-onset delirium allows prompt investigation and treatment.

  • Mistake: Using MMSE alone to diagnose dementia type

    Correction: MMSE is a global cognitive screen, not a diagnostic tool. It cannot differentiate between Alzheimer's disease, vascular dementia, Lewy body dementia, or frontotemporal dementia. Comprehensive clinical and neuropsychological evaluation is required.

  • Mistake: Applying standard cutoffs without age and education adjustment

    Correction: MMSE scores are significantly influenced by age and education. Normative data stratified by age and education should be used. A score of 24 may be normal for an 80-year-old with 8 years of education but abnormal for a 60-year-old with 16 years of education.

  • Mistake: Using MMSE in patients with aphasia or sensory deficits

    Correction: MMSE relies heavily on verbal responses and visual construction. In patients with aphasia, hearing loss, or visual impairment, consider alternative tools like the Modified MMSE (3MS) or the MoCA Blind.

  • Mistake: Scoring clock drawing as 1 point instead of 0 or 2

    Correction: The Mini-Cog clock is scored as either normal (2 points) or abnormal (0 points). There is no partial score. Any significant error makes the clock abnormal.

  • Mistake: Using total score only without applying the algorithm

    Correction: The Mini-Cog interpretation is algorithm-based, not score-based. A total score of 2 could mean different things: recall 0/3 + clock 2 (positive) vs recall 2/3 + clock 0 (positive). Always apply the algorithm steps.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Delirium; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

Frequently Asked Questions

Q: What is the target RASS score for most ICU patients?

For most mechanically ventilated patients, a target of RASS 0 to -1 is recommended by the PADIS guidelines. This provides comfortable light sedation while allowing neurological assessment.

Q: How is RASS different from the Ramsay Sedation Scale?

RASS has a wider range including agitation (+1 to +4), which the Ramsay scale (1-6, sedation only) does not include. RASS also has better inter-rater reliability.

Q: Should RASS be assessed before or after procedures?

RASS should be assessed consistently at the same time each day (usually during morning rounds), before and after sedation adjustments, and whenever clinical status changes.

Q: How does RASS relate to delirium assessment?

RASS is used as the first step in delirium assessment with CAM-ICU. If the patient is RASS -4 or -5 (deeply sedated/unarousable), CAM-ICU cannot be performed.

Q: Can RASS be used in non-intubated patients?

Yes. RASS can be used in any patient requiring sedation assessment, including non-intubated ICU patients, post-operative patients, and delirium monitoring.

Q: What is daily sedation interruption and how does RASS guide it?

Daily sedation interruption involves temporarily holding sedative infusions until the patient demonstrates awakening (RASS 0 to -1). It reduces mechanical ventilation duration and is guided by serial RASS assessments.

Q: How does RASS relate to CPOT pain assessment?

The PADIS guidelines recommend assessing pain first (with CPOT or BPS) before sedation. A patient with RASS +2 may be agitated due to pain — treating pain may normalize RASS without additional sedatives.

Q: What is the difference between CAM-ICU and ICDSC?

The CAM-ICU is a binary (positive/negative) assessment tool for delirium based on a 4-feature algorithm, while the Intensive Care Delirium Screening Checklist (ICDSC) is a continuous score (0-8) that rates the severity of delirium symptoms. Both are recommended by SCCM PADIS guidelines. CAM-ICU is more commonly used in research and has higher specificity; ICDSC provides a severity dimension. In clinical practice, both are valid and the choice depends on institutional preference.

Q: Can CAM-ICU be used in non-intubated patients?

Yes. CAM-ICU was originally validated in both intubated mechanically ventilated patients and non-intubated patients. It can be used across the spectrum of ICU patients regardless of intubation status. For non-intubated patients, the Attention Screening Exam can be done verbally or with picture cards.

Q: How often should CAM-ICU be performed?

The SCCM PADIS guidelines recommend delirium screening at least once per shift (every 8-12 hours) in all ICU patients, and more frequently if the patient is at high risk or exhibiting fluctuating mental status. Many protocols combine RASS and CAM-ICU assessment together at the start of each shift and after any change in sedation or clinical status.

Q: What is the difference between MMSE and MoCA?

The MMSE is less sensitive for mild cognitive impairment (MCI) compared to the MoCA (18% vs 90% sensitivity). The MoCA includes more executive function, language, and abstraction tasks. The MMSE is better established for tracking moderate-to-severe dementia progression. The MMSE is copyright-protected and requires licensing fees, while the MoCA is freely available for clinical use. Both take 5-10 minutes and score out of 30.

Q: Is the MMSE free to use?

The MMSE is copyright-protected by Psychological Assessment Resources (PAR) and requires a licensing fee for routine clinical use in many settings. The original Folstein MMSE is in the public domain in some jurisdictions. Free alternatives include the MoCA, Mini-Cog, and the Montreal Cognitive Assessment for MCI screening.

Q: How often should MMSE be repeated?

For dementia monitoring, MMSE is typically repeated every 6-12 months. An annual decline of 2-4 points is expected in Alzheimer's disease. More frequent testing (3-6 months) may be appropriate in early stages or after medication initiation. Less frequent testing is needed for stable patients.

Q: How long does Mini-Cog take to administer?

The Mini-Cog takes approximately 3 minutes to administer, making it one of the briefest validated cognitive screening tools. The 3-word recall takes about 1-2 minutes (including a distractor period), and the clock-drawing test takes about 1-2 minutes.

Q: Does Mini-Cog require special training?

No, the Mini-Cog requires no special training or certification. It can be administered by any healthcare professional including physicians, nurses, medical assistants, and social workers. The only materials needed are a pen and paper.

📚Evidence-Based References

[1]
Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-1344.PubMed (12421743)
[2]
Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult ICU Patients (PADIS). Crit Care Med. 2018;46(9):e825-e873.PubMed (30113379)
[3]
Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983-2991.PubMed (12799407)
[4]
Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial). Lancet. 2008;371(9607):126-134.PubMed (18191684)
[5]
Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.PubMed (23269131)
[6]
Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703-2710.PubMed (11730446)
[7]
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.PubMed (1202204)
[8]
Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;(3):CD010783.PubMed (25740785)
[9]
National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers (NG97). NICE; 2018.
[10]
Borson S, Scanlan JM, Chen PJ, et al. The Mini-Cog: a cognitive "vital signs" measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15(11):1021-1027.PubMed (11113982)
[11]
Borson S, Scanlan JM, Watanabe J, et al. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry. 2006;21(4):349-355.PubMed (16534776)
[12]
US Preventive Services Task Force. Screening for Cognitive Impairment in Older Adults: Recommendation Statement. JAMA. 2020;323(8):757-763.PubMed (32096858)
Call Us
WhatsApp